FINWIRES · TerminalLIVE
FINWIRES

$ERIC

28 stories mentioning ERICUpdated 11d ago

Every FINWIRES story that references ERIC, newest first.

What are analysts saying about ERIC?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on ERIC?

Research

Research Alert: CFRA Upgrades Opinion On Ads Of Ericsson To Buy From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We upgrade our rating to Buy and raise our 12-month target price to USD16 (USD13), pegged to target 2027 EV/EBITDA of 8.6x (6.9x), which is one standard deviation above the five-year historical mean of 6.9x. The higher multiple reflects improving earnings visibility, gradual recovery in telecom spending, expanding exposure to AI-related network infrastructure demand, and expectations for stronger margin quality supported by a higher software and services contribution over time. We maintain 2026 revenue at SEK243B (+1.8% Y/Y) and 2027 at SEK249B (+2.6% Y/Y), reflecting a gradual recovery in telecom spending, continued 5G network investments, improving contribution from Cloud Software and Services, and steady growth in Enterprise. We also maintain 2026 EPADS at SEK8.99 (-0.4% Y/Y) and 2027 EPADS at SEK9.23 (+2.7% Y/Y), reflecting resilient margins supported by cost optimization initiatives, efficiency measures, and improving software and services mix.

$ERIC
Asia Markets

European Equities Traded in the US as American Depositary Receipts Start Week on Flat Note in Monday Trading

European equities traded in the US as American depositary receipts opened the week on a flat note Monday morning, edging 0.08% higher to 1,835.34 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Cellectis (CLLS), which advanced 8.1% and 6.3% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Ericsson (ERIC), which increased 4.9% and 3.2% respectively.The decliners from continental Europe were led by consumer goods company Unilever (UL) and biopharmaceutical company Grifols (GRFS), which fell 1.9% and 1.3% respectively. They were followed by internet browser company Opera (OPRA) and accommodations booking site trivago (TRVG), which were down 1% each.The gainers from the UK were led by cruise line operator Carnival (CUK) and pharmaceutical company Silence Therapeutics (SLN), which rose 6.6% and 4.7% respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Amarin (AMRN), which were up 3.9% and 3.4% respectively.The decliners from the UK and Ireland were led by biopharmaceutical companies Akari Therapeutics (AKTX) and Mereo BioPharma Group (MREO), which lost 10% and 7.3% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software firm Endava (DAVA), which dropped 5.8% and 2.2% respectively.

$AKTX$AMRN$AUTL$BDRX$CLLS$CUK$DAVA$DBVT$ERIC$GRFS$MREO$OPRA$SLN$SQNS$TRVG$UL
Asia Markets

European Equities Traded in the US as American Depositary Receipts Higher in Tuesday Trading

European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.27% to 1,794.86 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by brewing firm Anheuser-Busch InBev (BUD) and medical device maker EDAP TMS (EDAP), which advanced 9% and 3% respectively. They were followed by telecommunications companies Ericsson (ERIC) and Nokia (NOK), which rose 2.5% and 2.4% respectively.The decliners from continental Europe were led by semiconductor company Sequans Communications (SQNS) and internet advertising firm Criteo (CRTO), which shed 9.7% and 3.9% respectively. They were followed by biotech firm BioNTech (BNTX) and consumer goods company Unilever (UL), which fell 3.1% and 0.6% respectively.The gainers from the UK were led by Biodexa Pharmaceuticals (BDRX) and insurance company Prudential (PUK), which climbed 32% and 2.2% respectively. They were followed by education company Pearson (PSO) and mining company BHP Group (BHP) were up 1.8% and 1.5% respectively.The decliners from the UK and Ireland were led by lender HSBC (HSBC) and Mereo BioPharma (MREO), which fell 5% and 2.1% respectively. They were followed by Lloyds Banking Group (LYG) and software firm Endava (DAVA), which were down 1.9% each.

$BDRX$BHP$BNTX$BUD$DAVA$EDAP$ERIC$HSBC$LYG$MREO$NOK$PSO$PUK$SQNS$UL
Asia Markets

European Equities Traded in the US as American Depositary Receipts Decline in Monday Trading

European equities traded in the US as American depositary receipts started the week tracking lower late Monday morning, as the S&P Europe Select ADR Index was falling 0.54% to 1,830.11.From continental Europe, the gainers were led by semiconductor company Sequans Communications (SQNS) and telecommunications company Ericsson (ERIC), which rose 5.3% and 3.9% respectively. They were followed by telecommunications company Nokia (NOK) and internet browser company Opera (OPRA), which increased 2.7% and 2.2% respectively.The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which dropped 7.7% and 3.9% respectively. They were followed by lender Banco Santander (SAN) and biopharmaceutical company Grifols (GRFS), which were down 2.5% and 2.4% respectively.The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and oil and gas company BP (BP), which advanced 15% and 1.4% respectively. They were followed by telecommunications operator Vodafone Group (VOD) and tobacco company British American Tobacco (BTI), which were up 1.1% and 0.5% respectively.The decliners from the UK and Ireland were led by biopharmaceutical company Akari Therapeutics (AKTX) and communications company WPP (WPP), which lost 7.5% and 2% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and cruise line operator Carnival (CUK), which fell 1.9% and 1.3% respectively.

$AKTX$BBVA$BDRX$BP$BTI$CLLS$CUK$ERIC$GRFS$NCNA$NOK$OPRA$SAN$SQNS$VOD$WPP
Asia Markets

European Equities Traded in the US as American Depositary Receipts Sharply Higher in Friday Trading

European equities traded in the US as American depositary receipts were climbing higher late Friday morning, rising 1.06% to 1,840.68 on the S&P Europe Select ADR Index, which has gained 1.42% for the week.From continental Europe, the gainers were led by lender Banco Santander (SAN) and software firm SAP (SAP), which advanced 5.3% and 4.2%, respectively. They were followed by healthcare tech company Royal Philips (PHG) and lender Banco Bilbao Vizcaya Argentaria (BBVA), which increased 4.1% each.The decliners from continental Europe were led by petroleum refiner Equinor (EQNR) and oil and gas company Eni (E), which dropped 9% and 7.4%, respectively. They were followed by telecommunications company Ericsson (ERIC) and medical device maker EDAP TMS (EDAP), which lost 6.2% and 3.6%, respectively.The gainers from the UK were led by cruise line operator Carnival (CUK) and biopharmaceutical company NuCana (NCNA), which rose 9.3% and 7.1%, respectively. They were followed by hospitality company InterContinental Hotels Group (IHG) and lender Barclays (BCS), which were up 4.7% and 4.6%, respectively.The decliners from the UK and Ireland were led by oil and gas companies BP (BP) and Shell (SHEL), which fell 8.1% and 5.2%, respectively. They were followed by telecommunications operator Vodafone Group (VOD) and biotech firm Trinity Biotech (TRIB), which were down 2.7% and 2.6%, respectively.

$BBVA$BCS$BP$CUK$E$EDAP$EQUINOR$ERIC$IHG$NCNA$PHG$SAN$SAP$SHEL$TRIB$VOD
Research

Research Alert: CFRA Keeps Hold Opinion On Adss Of Ericsson

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We keep our Hold rating and raise our 12-month target to USD13 from USD11, based on an EV/EBITDA multiple of 6.9x (7.0x), in line with its five-year average, applied to our 2027 EBITDA estimate of SEK47.9B. The multiple reflects a cautious stance on margin expansion given input cost pressures and a still-flat Radio Access Network (RAN) market. As Q1 2026 results were seasonally in line with expectations, we maintain our 2026 revenue estimate at SEK243B and 2027 at SEK249B, supported by stable demand from 5G deployments and improving contribution from Cloud Software and Services, partly offset by weaker North America trends. Hence, we also maintain our 2026 EPADS at SEK8.99 and 2027 at SEK9.23, reflecting cost discipline and improving mix, partly offset by ongoing input cost pressures. Earnings growth remains gradual, with near-term performance influenced by deal timing and cost headwinds, while margin improvement is expected to be supported by efficiency measures and improving business mix over time.

$ERIC
Research

Research Alert: Ericsson: Q1 2026 Core Earnings Meet Consensus, Margins Under Pressure

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:Ericsson's Q1 2026 core net income of SEK4.7B (-54% Q/Q, +12% Y/Y) was seasonally in line with consensus, while revenue declined to SEK49.3B (-29% Q/Q, -10% Y/Y) due to currency headwinds and lower North American network spending. Improving organic demand across all segments reflects continued 5G deployments and geographic diversification, supported by growth in the Networks, Cloud Software and Services, and Enterprise segments. Management expects the RAN market to remain flattish in 2026, with Q2 growth aligned with historical seasonality. Networks' adjusted EBITA margin declined to 19.3% from 21.0% due to higher semiconductor costs and supply chain pressures, while Cloud Software improved to 5.3% from 1.2% on better efficiency and product mix. Enterprise continues to weigh on profitability with a -34.6% EBITA margin. We believe gradual earnings progression is expected in 2H 2026 as cost discipline and efficiency measures support margin recovery despite ongoing input cost pressures.

$ERIC
Asia Markets

European Equities Traded in the US as American Depositary Receipts Trending Lower in Wednesday Trading

European equities traded in the US as American depositary receipts were heading lower late Wednesday morning, declining 0.54% to 1,835.78 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by medical device maker EDAP TMS (EDAP) and biopharmaceutical firm Grifols (GRFS), which advanced 3% and 2.6%, respectively. They were followed by software company SAP (SAP) and biopharmaceutical company argenx (ARGX), which increased 2.5% each.The decliners from continental Europe were led by furniture maker Natuzzi (NTZ) and telecommunications company Nokia (NOK), which dropped 4.2% and 1.6%, respectively. They were followed by telecommunications company Ericsson (ERIC) and petroleum refiner Equinor (EQNR), which lost 1.5% and 1.2%, respectively.The gainers from the UK were led by biopharmaceutical company Biodexa Pharmaceuticals (BDRX) and software company Endava (DAVA), which rose 3.2% each. They were followed by biopharmaceutical companies Amarin (AMRN) and NuCana (NCNA), which were up 3% and 2.3% respectively.The decliners from the UK and Ireland were led by biotech firm Trinity Biotech (TRIB) and biopharmaceutical company Mereo BioPharma Group (MREO), which fell 2.9% and 2.6% respectively. They were followed by pharmaceutical company AstraZeneca (AZN) and utilities company National Grid (NGG), which were down 1.3% and 1.2% respectively.

$AMRN$ARGX$AZN$DAVCA$EDAP$EQNR$ERIC$GRFS$MREO$NCNA$NGG$NOK$NTZ$SAP$TRIB$VDRZ

Showing 21-28 of 28

Track with the FINWIRES app suite

FolioX
FolioX
Track ERIC in your portfolio
WheelAI
WheelAI
Analyze ERIC options with the wheel strategy
StockInsider
StockInsider
See market sentiment on ERIC